| Novo Nordisk A/s Class B | 67,891 | US$3.11M | 3.8% |
| Eli Lilly And Company | 2,652 | US$2.93M | 3.6% |
| Edwards Lifesciences Corporation | 31,927 | US$2.76M | 3.4% |
| Roche Holding Ltd | 6,234 | US$2.63M | 3.2% |
| Abbvie Inc. | 11,869 | US$2.58M | 3.2% |
| Welltower Inc. | 12,218 | US$2.51M | 3.1% |
| Ventas, Inc. | 29,677 | US$2.51M | 3.1% |
| Merck & Company, Inc. | 20,617 | US$2.45M | 3.0% |
| Bristol-myers Squibb Company | 42,594 | US$2.44M | 3.0% |
| Amgen Inc. | 7,123 | US$2.4M | 2.9% |
| Johnson & Johnson | 10,447 | US$2.35M | 2.9% |
| Ucb S.a. | 7,976 | US$2.34M | 2.9% |
| Astrazeneca Plc | 12,330 | US$2.29M | 2.8% |
| Stryker Corporation | 7,469 | US$2.28M | 2.8% |
| Chugai Pharmaceutical Co., Ltd. | 45,915 | US$2.28M | 2.8% |
| Sandoz Group Ltd | 25,507 | US$2.14M | 2.6% |
| Medtronic Plc. | 28,814 | US$2.13M | 2.6% |
| Regeneron Pharmaceuticals, Inc. | 3,299 | US$2.03M | 2.5% |
| Boston Scientific Corporation | 41,335 | US$2M | 2.4% |
| Alcon Ag | 28,830 | US$1.92M | 2.3% |
| Beone Medicines Ltd. Class A | 6,362 | US$1.83M | 2.2% |
| Celltrion, Inc. | 13,398 | US$1.71M | 2.1% |
| Dexcom, Inc. | 22,316 | US$1.65M | 2.0% |
| Astellas Pharma Inc. | 105K | US$1.5M | 1.8% |
| United Therapeutics Corporation | 2,537 | US$1.41M | 1.7% |
| Hansoh Pharmaceutical Group Company Limited | 349K | US$1.4M | 1.7% |
| Terumo Corporation | 85,565 | US$1.29M | 1.6% |
| Straumann Holding Ag | 9,223 | US$1.12M | 1.4% |
| Incyte Corporation | 11,515 | US$1.11M | 1.4% |
| Genmab A/s | 3,726 | US$991K | 1.2% |
| Zimmer Biomet Holdings, Inc. | 11,291 | US$930K | 1.1% |
| Sonova Holding Ag | 3,457 | US$919K | 1.1% |
| Neurocrine Biosciences, Inc. | 5,792 | US$917K | 1.1% |
| Omega Healthcare Investors, Inc. | 17,057 | US$798K | 0.97% |
| Exelixis, Inc. | 14,988 | US$757K | 0.92% |
| Davita Inc. | 3,855 | US$749K | 0.92% |
| Smith & Nephew Plc | 49,312 | US$738K | 0.90% |
| Fresenius Medical Care Ag | 16,934 | US$735K | 0.90% |
| Insulet Corporation | 4,082 | US$592K | 0.72% |
| The Ensign Group, Inc. | 3,354 | US$562K | 0.69% |
| Demant A/s | 12,397 | US$484K | 0.59% |
| Halozyme Therapeutics, Inc. | 6,843 | US$455K | 0.56% |
| Aedifica Sa | 4,817 | US$398K | 0.49% |
| Novocure Limited | 23,028 | US$392K | 0.48% |
| Mannkind Corporation | 98,947 | US$373K | 0.46% |
| Ypsomed Holding Ag | 788 | US$353K | 0.43% |
| Glaukos Corporation | 3,368 | US$348K | 0.43% |
| Teleflex Incorporated | 2,551 | US$328K | 0.40% |
| Cg Oncology, Inc. | 4,873 | US$304K | 0.37% |
| Livanova Plc | 3,997 | US$295K | 0.36% |
| Amplifon Spa | 23,225 | US$292K | 0.36% |
| Sabra Health Care Reit, Inc. | 14,551 | US$289K | 0.35% |
| Clariane Se | 57,561 | US$281K | 0.34% |
| Extendicare Inc. | 11,852 | US$279K | 0.34% |
| Sonida Senior Living, Inc. | 7,753 | US$274K | 0.33% |
| Ryman Healthcare Ltd. | 202K | US$274K | 0.33% |
| Chartwell Retirement Residences | 18,672 | US$274K | 0.33% |
| Pharma Mar Sa | 2,343 | US$273K | 0.33% |
| Emeis | 15,663 | US$272K | 0.33% |
| Cochlear Limited | 3,765 | US$272K | 0.33% |
| Nipro Corporation | 24,549 | US$265K | 0.32% |
| National Healthcare Corporation | 1,426 | US$263K | 0.32% |
| Integer Holdings Corporation | 2,923 | US$261K | 0.32% |
| Gn Store Nord A/s | 16,978 | US$260K | 0.32% |
| Elekta Ab Class B | 43,842 | US$255K | 0.31% |
| Theravance Biopharma, Inc. | 15,305 | US$246K | 0.30% |
| Medacta Group Sa | 1,337 | US$245K | 0.30% |
| Acadia Pharmaceuticals Inc. | 11,223 | US$243K | 0.30% |
| Ltc Properties, Inc. | 6,374 | US$238K | 0.29% |
| Brookdale Senior Living Inc. | 18,355 | US$236K | 0.29% |
| Sienna Senior Living Inc. | 15,185 | US$233K | 0.29% |
| Merit Medical Systems, Inc. | 3,690 | US$233K | 0.28% |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A | 28,403 | US$227K | 0.28% |
| Agios Pharmaceuticals, Inc. | 7,695 | US$226K | 0.28% |
| Lifetech Scientific Corporation | 1.04M | US$220K | 0.27% |
| National Health Investors, Inc. | 2,928 | US$215K | 0.26% |
| Ak Medical Holdings Ltd. | 284K | US$212K | 0.26% |
| Microport Scientific Corp. | 219K | US$210K | 0.26% |
| Innocare Pharma Ltd. Class A | 131K | US$194K | 0.24% |
| Luye Pharma Group Ltd. | 696K | US$193K | 0.24% |
| Lepu Biopharma Co. Ltd. Class H | 345K | US$188K | 0.23% |
| Beijing Chunlizhengda Medical Instruments Co., Ltd. Class A | 149K | US$180K | 0.22% |
| Alphatec Holdings, Inc. | 22,882 | US$177K | 0.22% |
| Embecta Corp. | 28,422 | US$96,066 | 0.12% |
| Denali Therapeutics Inc. | 0 | US$0 | 0.00% |
| Dentium Co., Ltd. | 0 | US$0 | 0.00% |